Abstract:

Purpose: In patients with advanced stage pleural ampyema (PA) diagnosis with toracoscopic debridman (TD), the evaluation of the effect of the time of toracoscopy on morbidity. Instruments and Methods: Patients with advanced stage PA diagnosis between January 2010 and March 2019 were recurrently assessed in terms of symptom duration, post-TD breast tube stay duration, hospital stay duration, additional attempts and complications. In patients with TD, the symptom duration was calculated. The symptom duration was compared with the patients that were above this value and below. The data was analyzed in the IBM SPSS program. p <0,05 was statistically considered meaningful. Results: 98 patients diagnosed with PA were included in the advanced stage of the study. 52 patients were first infected with breast pipe. Nine (17.3%) patients were healed by breast tubes, while 46 patients were given TD to 89 patients, the first attempt. The symptom duration of the patient is an average of 10 days (4-60 days). The period of residence of the breast tube after TD is 10 days and the period of symptoms is 8 days (3-12 days) and the period of symptoms is 14 days (3-30 days). The duration of stay in the hospital, the duration of the symptoms is 10 days and the average of those under 10.5 days (4-26 days), and those above 20 days (4-56 days). The period of residence of the breast tube after TD and the period of residence in the hospital the symptom duration was statistically significantly lower in those of 10 days and below, compared to those above (p <0,05). 1 (1.12%) of patients developed broncho-oplevral fistles after TD. 5 (5.61) patients needed second TD, and 4 (4.49) patients needed toracotomy. One (1.02) of the patients was lost. Result: TD is an effective method in advanced stage PA treatment. Advanced stage PA is considered to reduce morbidity by providing early healing without time losing in patients.

Keywords: